Rankings
▼
Calendar
KNSA (Kiniksa Pharmaceuticals, Ltd.) Stock Financials & Earnings | Market Cap Arena
KNSA
Kiniksa Pharmaceuticals, Ltd.
Mkt Cap
$3B
Healthcare
·
Biotechnology
·
🇧🇲 Bermuda
·
NASDAQ
Revenue (TTM)
$678M
Net Income (TTM)
$59M
EPS (TTM)
$0.75
Free Cash Flow (TTM)
$136M
Gross Margin
54.6%
Op. Margin
11.4%
Net Margin
8.7%
FCF Margin
20.1%
P/S Ratio (TTM)
5.1x
P/E Ratio (TTM)
59.1x
YoY Rev Growth
+60.1%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$48M
$32M
-$11M
Q2 23
$71M
$49M
-$3M
Q3 23
$67M
$40M
-$11M
Q4 23
$83M
$57M
$81K
Q1 24
$80M
$48M
-$17M
Q2 24
$109M
$66M
-$117K
Q3 24
$112M
$63M
-$10M
Q4 24
$123M
$56M
-$19M
Q1 25
$138M
$76M
$13M
Q2 25
$157M
$86M
$20M
Q3 25
$181M
$97M
$24M
Q4 25
$202M
$111M
$20M
marketcaparena.com
Revenue Breakdown
KNSA
Kiniksa Pharmaceuticals, Ltd.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
14.7x
17.7x
Q2 23
12.4x
15.1x
Q3 23
14.0x
—
Q4 23
12.9x
247.4x
Q1 24
11.5x
402.8x
Q2 24
10.3x
—
Q3 24
9.1x
—
Q4 24
8.2x
—
Q1 25
7.2x
—
Q2 25
6.6x
727.4x
Q3 25
5.8x
97.0x
Q4 25
5.1x
59.1x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$4M
-$4M
Q2 23
-$4M
-$4M
Q3 23
$17M
$17M
Q4 23
$4M
$4M
Q1 24
$4M
$4M
Q2 24
$5M
$5M
Q3 24
-$2M
-$2M
Q4 24
$19M
$19M
Q1 25
$22M
$22M
Q2 25
$28M
$28M
Q3 25
$34M
$33M
Q4 25
$54M
$53M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$24K
Q2 23
$34K
Q3 23
$16K
Q4 23
$56K
Q1 24
$84K
Q2 24
$0
Q3 24
$0
Q4 24
$193K
Q1 25
$99K
Q2 25
$165K
Q3 25
$671K
Q4 25
$633K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+50.2%
+7.3%
Q2 23
+165.0%
+61.0%
Q3 23
-32.4%
+47.9%
Q4 23
+34.8%
+49.2%
Q1 24
+65.2%
+61.9%
Q2 24
+52.0%
+45.7%
Q3 24
+67.4%
+56.3%
Q4 24
+46.9%
+70.2%
Q1 25
+72.5%
+29.2%
Q2 25
+44.3%
+25.6%
Q3 25
+61.2%
+28.7%
Q4 25
+65.0%
+28.6%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$6M
12.6%
Q2 23
$6M
9.1%
Q3 23
$7M
10.1%
Q4 23
$8M
9.3%
Q1 24
$7M
9.0%
Q2 24
$7M
6.8%
Q3 24
$8M
7.0%
Q4 24
$8M
6.8%
Q1 25
$8M
5.6%
Q2 25
$9M
5.7%
Q3 25
$10M
5.6%
Q4 25
$4M
1.9%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$15M
$28M
Q2 23
$23M
$28M
Q3 23
$17M
$34M
Q4 23
$20M
$37M
Q1 24
$26M
$39M
Q2 24
$24M
$42M
Q3 24
$26M
$46M
Q4 24
$35M
$41M
Q1 25
$19M
$44M
Q2 25
$19M
$47M
Q3 25
$24M
$49M
Q4 25
$35M
$57M
marketcaparena.com
Revenue Segments
Collaboration
Product
Quarter
Collaboration
Product
Q1 23
$6M
$43M
Q2 23
$17M
$54M
Q3 23
$2M
$65M
Q1 24
$973K
$79M
Q2 24
$5M
$103M
Q1 25
—
$138M
Q2 25
—
$157M
Q3 25
—
$181M
Q4 25
—
$202M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$81M
$107M
$187M
Q2 23
$113M
$72M
$185M
Q3 23
$118M
$83M
$201M
Q4 23
$108M
$98M
$206M
Q1 24
$141M
$72M
$214M
Q2 24
$99M
$119M
$219M
Q3 24
$97M
$126M
$224M
Q4 24
$184M
$60M
$244M
Q1 25
$157M
$111M
$268M
Q2 25
$192M
$116M
$308M
Q3 25
$175M
$177M
$352M
Q4 25
$166M
$248M
$414M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
70M
-2.3%
Q2 23
72M
+2.7%
Q3 23
70M
-2.0%
Q4 23
73M
+3.5%
Q1 24
71M
-2.8%
Q2 24
71M
+0.5%
Q3 24
72M
+1.0%
Q4 24
72M
+0.8%
Q1 25
76M
+5.3%
Q2 25
78M
+2.4%
Q3 25
78M
+0.1%
Q4 25
79M
+1.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
$0
111
FY 19
$0
137
FY 20
$0
168
FY 21
$179K
215
FY 22
$1M
220
FY 23
$910K
297
FY 24
$1M
315
FY 25
$3K
200K
marketcaparena.com